skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Persistent uptake of indium-111-antimyosin monoclonal antibody in patients with myocardial infarction

Journal Article · · American Heart Journal; (USA)

Indium-111(111In)-antimyosin scintigraphy was investigated in 27 patients with myocardial infarction. {sup 111}In-antimyosin Fab was administered intravenously, and planar and single photon emission computed tomographic images were obtained 48 hours later. Uptake of {sup 111}In-antimyosin was present in 9 of 10 patients (90%) studied within 6 days of infarction. During the second week positive scans were seen in 16 of 16 patients (100%) including 13 (81%) who had normal creatine kinase levels. The mechanism of persistent positive antimyosin images in the subacute stage of myocardial infarction remains to be clarified. {sup 111}In-antimyosin scintigraphy may be useful as a noninvasive method for the detection of myocardial injury late and early after a suspected acute myocardial infarction.

OSTI ID:
6322825
Journal Information:
American Heart Journal; (USA), Vol. 120:5; ISSN 0002-8703
Country of Publication:
United States
Language:
English

Similar Records

Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab
Journal Article · Sun Nov 01 00:00:00 EST 1987 · J. Nucl. Med.; (United States) · OSTI ID:6322825

Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization
Journal Article · Sun Jan 01 00:00:00 EST 1989 · Am. J. Cardiol.; (United States) · OSTI ID:6322825

Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: Comparison with technetium-99m-pyrophosphate imaging
Journal Article · Thu Feb 01 00:00:00 EST 1990 · Journal of Nuclear Medicine; (USA) · OSTI ID:6322825